Three drugs push CBO to raise orphan cost estimate to $8.8B over 10 yearsnews2025-10-20T18:16:04+00:00October 20th, 2025|Endpoints News|
Celcuity’s shares rally after ESMO readouts; Disc Medicine’s $220M stock salenews2025-10-20T15:24:27+00:00October 20th, 2025|Endpoints News|
#ESMO25: Roche says ctDNA-guided Tecentriq prolonged survival in bladder cancer patientsnews2025-10-20T15:10:59+00:00October 20th, 2025|Endpoints News|
RAPT, Jeyou are itching to start Phase 3 after encouraging mid-stage results in urticarianews2025-10-20T15:04:55+00:00October 20th, 2025|Endpoints News|
#ESMO25: Novartis seeks to move Pluvicto to earlier prostate cancer, but data underwhelmnews2025-10-20T14:37:56+00:00October 20th, 2025|Endpoints News|
Weight management and primary care startup knownwell raises $25Mnews2025-10-20T12:01:42+00:00October 20th, 2025|Endpoints News|
#ESMO25: Iambic Therapeutics gives first clinical readout for AI-designed cancer drugnews2025-10-20T11:00:14+00:00October 20th, 2025|Endpoints News|
Interview with Anthropic’s life sciences head on AI in bio productnews2025-10-20T10:00:16+00:00October 20th, 2025|Endpoints News|
#ESMO25: Ideaya’s drug saves almost 60% of eye cancer patients from surgery in Phase 2 trialnews2025-10-20T09:48:53+00:00October 20th, 2025|Endpoints News|
Eli Lilly backs anti-aging biotech NewLimit in $45M raisenews2025-10-20T09:00:12+00:00October 20th, 2025|Endpoints News|
